By collaborating with strategic industry partners and leading academic centers, Secant Medical Components’ translational science program strives to identify and provide advanced biomaterial technology to address the future needs of the medical device industry. Our partnerships include:
Atvio-Biotech (Part of the MasTherCell Global network) is a specialized process and product development firm focused on costume-made process development, upscaling design from lab to industry innovation and automation procedures, which are extremely essential in the cell therapy industry. Secant Group and Atvio-Biotech were awarded a grant from the BIRD Foundation to develop a platform for 3D therapeutic cell cultures using advanced biomaterials. The BIRD Foundation promotes collaboration between U.S. and Israeli companies in various technological fields for the purpose of joint product development.
DSM offers high-performance UHMWPE fiber
with the necessary biomechanical and biocompatible properties to innovate biomedical textile structures.
Our collaboration with Solvay Advanced Polymers promotes the development and production of implantable biomedical structures made of Zeniva® PEEK fiber for devices in cardiovascular, neurovascular, orthopedics, tissue engineering, and general surgery.
The Institute of NanoBioTechnology
at Johns Hopkins University unites researchers from the university’s various schools to generate new concepts and technologies at the intersection of nanoscience and medicine.